OBI Pharma
Manufacturing · Taiwan · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Nankang Software Park 19f Park St 3-2, T...Phone Number
(619) 537-7698Website
www.obipharma.comRevenue
$9.7 MillionIndustry
About OBI Pharma
OBI Pharma is a clinical-stage global oncology company focused on developing novel therapeutic agents, particularly antibody-drug conjugates (ADCs), for patients with unmet medical needs. The company operates with a strong emphasis on research and development, showcasing advanced technologies and a robust pipeline of innovative cancer therapies. OBI Pharma aims to expand its reach internationally while maintaining a commitment to employee well-being and sustainability. Their intended clients include healthcare providers and patients seeking cutting-edge cancer treatments.Explore more
OBI Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to OBI Pharma
Compare insights from companies similar to OBI Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$31.5M
51-200
Public
$458.6M
2018
SC
Sushmita ChandaExecutive Vice President & Chief Development Officer
OBI Pharma Tech Stack
A closer look at the technologies used by OBI Pharma
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OBI Pharma
Sign Up For FreeTo access detailed company insights
OBI Pharma is a clinical-stage global oncology company focused on developing novel therapeutic agents, particularly antibody-drug conjugates (ADCs), for patients with unmet medical needs. The company operates with a strong emphasis on research and development, showcasing advanced technologies and a robust pipeline of innovative cancer therapies. OB... Read More
